跳至主要内容
临床试验/NCT07340450
NCT07340450已完成不适用

Comparison of Oral vs Intravenous Iron Therapy for the Treatment of Postpartum Anemia

Shahida Islam Medical Complex1 个研究点 分布在 1 个国家目标入组 122 人开始时间: 2025年2月18日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
122
试验地点
1
主要终点
Change in hemoglobin level

研究概览

简要总结

Postpartum anemia is a common condition associated with adverse maternal outcomes. This study aimed to compare the effectiveness of oral iron therapy versus intravenous iron therapy in women with postpartum anemia.

详细描述

This randomized, open-label, parallel-group study was conducted at Shahida Islam Medical College and Hospital, Lodhran, Pakistan. Women diagnosed with postpartum anemia who fulfilled the eligibility criteria were randomly allocated using a lottery method to receive either intravenous iron (ferric carboxymaltose) or oral iron therapy (ferrous sulfate). The primary outcome was the change in hemoglobin level from baseline to 6 weeks of follow-up.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • All women with postpartum anaemia as per operational definition i.e Haemoglobin <11 g/dl at 24 hours after delivery (either caesarean or SVD).
  • Age 20-40 years.
  • Pre-operative haemoglobin >10 g/dl.
  • Both primiparous and multiparous.
  • Both primigravida and multigravida.

排除标准

  • Iron Intolerance or previous history of allergy to iron
  • Parenteral Iron hypersensitivity
  • Patients with thalassemia
  • Indication of blood transfusion
  • Patients with bleeding/ clotting disorders
  • Patients with postpartum haemorrhage
  • Patients with chronic diseases.

研究组 & 干预措施

Group A: Intravenous Iron Therapy

Experimental

Participants received intravenous iron therapy for the treatment of postpartum anemia

干预措施: Ferric Carboxy Maltose (Drug)

Group B: Oral Iron Therapy

Experimental

Participants received oral iron therapy for the treatment of postpartum anemia.

干预措施: Ferrous Sulfate (Drug)

结局指标

主要结局

Change in hemoglobin level

时间窗: Baseline to 6 weeks postpartum

次要结局

未报告次要终点

研究者

发起方
Shahida Islam Medical Complex
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sidra Jalil Khan

PGR obstetrics and Gynaecology

Shahida Islam Medical Complex

研究点 (1)

Loading locations...

相似试验